BioVisioN AG

Peptidomics company names new chief scientific officer

Published in Law and Health Weekly, January 12th, 2004

BioVisioN AG has appointed Peter Schulz-Knappe chief scientific officer (CSO) and member of the executive board of BioVisioN AG effective January 1, 2004.

He replaces in this position Rudolf Reiter who has left the board effective December 2003. Schulz-Knappe is one of the founders of BioVisioN AG and had been CEO of the company until April 2003.

Rainer Voegeli has joined the management team of the company as chief business officer (CBO) and head of business development and marketing. Voegeli has gained his management experience at various positions over several years in the pharmaceutical industry (ASTA Medica AG) as well as in the biotech industry...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2004-01-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry